Both in Pharmaceuticals
Stoke Therapeutics vs Nurix Therapeutics
Over the past year STOK returned +8.3% and NRIX returned +30.1%; their daily moves had a correlation of 0.27.
STOK +8.3% NRIX +30.1%Growth of $1, one year, split-adjusted
| Metric | STOK | NRIX |
|---|---|---|
| Price | $27.45 | $15.95 |
| Market cap | $1.77B | $1.74B |
| Today | +1.70% | −38.23% |
| 1 month | +12.6% | −29.4% |
| 6 months | −17.5% | −5.5% |
| Year to date | −13.5% | −15.9% |
| 1 year | +5.2% | +26.4% |
| Revenue growth (YoY) | +5.9% | +8426.3% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −654.3% | 81.7% |
| P/E (TTM) | — | 5.9× |
| Price / sales | 62.8× | 2.5× |
| Net cash | $319.2M | $1.05B |
| Dividend yield | — | — |
| Volatility (60d) | 47.9% | 104.6% |
| Short % of float | 18.9% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).